The Diagnosis and Mechanism of Pleural… | Clinical Trial

Key information

Conditions

Pleural Diseases Respiratory Tract Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Jinshuo Fan

Wuhan, State..., 430022, China

About this study

The diagnosis and treatment of benign and malignant pleural effusions, the mechanisms of pleural diseases

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with pleural effusion, who has not been treated

Exclusion criteria

Patients with pleural effusion, who has already been treated

Treatment and study plan

Collection of pleural effusion

Other

Detection of pleural effusion

Primary outcomes

overall survival

Time frame: 1 years

the percentage of people in a group who are alive after a year for malignant pleural effusion

Sponsors and collaborators

Lead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Other

Registry information

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2021
First posted: Jun 25, 2019
Registry last updated: Nov 16, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed